Indusind Bank Ltd (INDUSINDBK)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q4FY23 net profit 2,043cr +46% y-y, +4% q-q; annual PAT 7,443cr +55% y-y
- Loan growth 21% y-y, 6% q-q; retail loans now 54% of book
- NIM stable at 4.28%, ROA 1.9%, ROE 15.26%, CRAR 17.86%
- GNPA 1.98%, NNPA 0.59%; credit cost 142bps vs 156bps q-q
- Planning Cycle 6 targets: loan growth 18-23%, retail deposits 45-50%, PPOP/loans 5.25-5.75%, ROA 1.9-2.2%
- Vehicle finance disbursements up 25% q-q; microfinance rebounding with 30% q-q disbursements growth
- Digital initiatives progressing; new app launch planned this quarter
- Guidance: credit cost 110-130bps; NIM 4.25-4.35% in PC6
- Branch expansion ongoing; focus on retail deposit granularisation
- Conservative provisioning maintained with PCR at 71%
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INDUSINDBK — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INDUSINDBK to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Indusind Bank Ltd
Important.
The summary above is generated automatically from Indusind Bank Ltd's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.